X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
humans (14) 14
immunotherapy (12) 12
oncology (11) 11
article (10) 10
cross-presentation (7) 7
immunology (7) 7
t-lymphocytes, cytotoxic - immunology (7) 7
female (6) 6
animals (5) 5
antigen (5) 5
breast cancer (5) 5
cancer (5) 5
cell line, tumor (5) 5
expression (5) 5
hla-a2 antigen - immunology (5) 5
neutrophil elastase (5) 5
t cells (5) 5
acute myeloid-leukemia (4) 4
antigens (4) 4
antigens, neoplasm - immunology (4) 4
breast neoplasms - immunology (4) 4
cd8-positive t-lymphocytes - immunology (4) 4
cytotoxicity (4) 4
cytotoxicity, immunologic (4) 4
leukemia (4) 4
leukocyte elastase - immunology (4) 4
leukocyte elastase - metabolism (4) 4
lymphocytes (4) 4
lymphocytes t (4) 4
melanoma (4) 4
melanoma - immunology (4) 4
mice (4) 4
tumor cells, cultured (4) 4
adaptive immunity (3) 3
antigen presentation (3) 3
antigen-presenting cells - immunology (3) 3
antigens, neoplasm - metabolism (3) 3
breast neoplasms - metabolism (3) 3
breast neoplasms - pathology (3) 3
cd8 antigen (3) 3
chronic myelogenous leukemia (3) 3
cytotoxic t-lymphocytes (3) 3
exogenous antigens (3) 3
flow cytometry (3) 3
gene expression (3) 3
health aspects (3) 3
hematology (3) 3
hemic and lymphatic diseases (3) 3
hla-a2 antigen - metabolism (3) 3
immunity (3) 3
immunotherapy, adoptive (3) 3
innovations (3) 3
leukemia, myeloid, acute - metabolism (3) 3
leukemia, myeloid, acute - therapy (3) 3
myeloblastin - immunology (3) 3
pr1 (3) 3
research (3) 3
serine proteases (3) 3
t-lymphocytes, cytotoxic - metabolism (3) 3
therapy (3) 3
tumor-infiltrating lymphocytes (3) 3
adoptive transfer (2) 2
adult (2) 2
aged (2) 2
aged, 80 and over (2) 2
antigen presentation - immunology (2) 2
antigen-presenting cells (2) 2
apoptosis (2) 2
b-cells (2) 2
care and treatment (2) 2
cathepsin-g (2) 2
cathepsins (2) 2
cd28 antigen (2) 2
cd8 t-cells (2) 2
cell activation (2) 2
cell line (2) 2
cells (2) 2
complex class-i (2) 2
cross-priming (2) 2
cross-priming - immunology (2) 2
ctl (2) 2
cytokines (2) 2
dendritic cells (2) 2
dendritic cells - immunology (2) 2
differentiation (2) 2
elastase (2) 2
expansion (2) 2
generation (2) 2
genetic aspects (2) 2
histocompatibility antigens (2) 2
histocompatibility antigens class i - immunology (2) 2
hla class-i (2) 2
hla histocompatibility antigens (2) 2
leukemia, myeloid, acute - immunology (2) 2
leukocyte elastase - chemistry (2) 2
lymphocyte activation (2) 2
lymphocytes b (2) 2
lymphocytes, tumor-infiltrating - immunology (2) 2
male (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e60031
Adoptive T-cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) can induce tumor regression in up to 50% or more of patients with unresectable... 
REGRESSION | RESPONSES | IMMUNOTHERAPY | PERSISTENCE | MULTIDISCIPLINARY SCIENCES | 4-1BB | ANTIGEN-PRESENTING CELLS | COSTIMULATION | GENERATION | EXPRESSION | CHEMOTHERAPY | Proto-Oncogene Proteins c-bcl-2 - immunology | Gene Expression - drug effects | CD8-Positive T-Lymphocytes - transplantation | Inhibitor of Apoptosis Proteins - genetics | Humans | Tumor Necrosis Factor Receptor Superfamily, Member 9 - genetics | Immunologic Memory - drug effects | CD28 Antigens - genetics | Melanoma - genetics | Immunoglobulin G - pharmacology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - agonists | Tumor Cells, Cultured | Skin Neoplasms - pathology | Cell Survival - drug effects | Immunotherapy, Adoptive | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology | Lymphocytes, Tumor-Infiltrating - transplantation | CD28 Antigens - immunology | Lymphocytes, Tumor-Infiltrating - drug effects | Melanoma - pathology | Signal Transduction - drug effects | Lymphocyte Activation - drug effects | Melanoma - immunology | CD8-Positive T-Lymphocytes - drug effects | Skin Neoplasms - genetics | Inhibitor of Apoptosis Proteins - immunology | Cell Proliferation - drug effects | CD8-Positive T-Lymphocytes - immunology | Melanoma - therapy | Proto-Oncogene Proteins c-bcl-2 - genetics | Lymphocytes, Tumor-Infiltrating - immunology | Therapy | Bcl-2 protein | CD8 antigen | Immunoglobulin G | Science | Effector cells | Cytotoxicity | Oncology | Stimulation | Lymphocytes T | Metastasis | CD28 antigen | Cancer therapies | Adoptive transfer | Anticancer properties | Metastases | T-cell receptor | Infusion | Antitumor agents | Immunology | Lymphocytes | Immunotherapy | Peripheral blood mononuclear cells | Expansion | Antigens | Immunological memory | Memory cells | Cell survival | CD137 antigen | Cytokines | Tumor-infiltrating lymphocytes | Melanoma | Survivin | Regression analysis | Gene expression | Patients | Survival | Signaling | Tumor necrosis factor | Stem cells | Apoptosis
Journal Article
Cancer Research, ISSN 0008-5472, 10/2017, Volume 77, Issue 19, pp. 5374 - 5383
Early-phase clinical trials evaluating CD8(+) T cell-eliciting, HER2-derived peptide vaccines administered to HER2(+) breast cancer patients in the adjuvant... 
IMMUNE-COMPLEXES | RESPONSES | FC-GAMMA RECEPTORS | ONCOLOGY | IN-VIVO | ANTIGEN PRESENTATION | INDUCTION | EXPRESSION | PROTOONCOGENE | CD8(+) T-CELLS | BREAST | T-Lymphocytes, Cytotoxic - immunology | Cell Proliferation | Trastuzumab - therapeutic use | Breast Neoplasms - immunology | Dendritic Cells - immunology | Humans | Receptor, ErbB-2 - metabolism | Mice, Transgenic | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Cancer Vaccines - therapeutic use | Vaccines, Subunit - therapeutic use | Animals | Female | Mice | Mice, Inbred BALB C | Ovarian Neoplasms - metabolism | Receptor, ErbB-2 - immunology | Tumor Cells, Cultured | CD8-Positive T-Lymphocytes - immunology | Ovarian Neoplasms - drug therapy | Apoptosis | Ovarian Neoplasms - immunology | Flow cytometry | Therapy | Animal models | CD8 antigen | Vaccination | Medical services | Clinical trials | Cytotoxicity | Lymphocytes T | Vaccines | Immunity | Cell activation | Lymphocytes | Immune system | Medical research | Antigen presentation | Immune response | Dendritic cells | Granulocyte-macrophage colony-stimulating factor | Breast cancer | T cell receptors | Adaptive immunity | Patients | ErbB-2 protein | Fc receptors | Cytometry | Monoclonal antibodies | Antitumor activity | Trastuzumab | Cancer | trastuzumab | breast cancer | dendritic cells | cross-presentation | HER2
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 3243 - 3243
Introduction: 
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 06/2017, Volume 292, Issue 24, pp. 10295 - 10305
Journal Article
Journal of Immunology, ISSN 0022-1767, 12/2012, Volume 189, Issue 11, pp. 5476 - 5484
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2013, Volume 19, Issue 1, pp. 247 - 257
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2012, Volume 18, Issue 9, pp. 2465 - 2477
Journal Article
Cancer Research, ISSN 0008-5472, 7/2012, Volume 72, Issue 13, pp. 3153 - 3162
There is little understanding of the impact of tumor-associated neutrophils (TAN) on adaptive immunity to tumors. In this study, we report the results of an... 
cyclin E | breast cancer | innate immunity | neutrophil elastase | adaptive immunity
Journal Article